A randomized trial found that the use of UV-C machines can cut transmission of four major superbugs by a cumulative 30 percent, according to an article on the Infection Control Today website.
The study was led by Duke Health and published in The Lancet. Its results are specific to patients who stay overnight in a room where someone with a known positive culture or infection of a drug-resistant organism had previously been treated.
The researchers focused on: MRSA, vancomycin-resistant enterococci (VRE), C. difficile and Acinetobacter.
The facilities studied used a portable machine called the Tru-D SmartUV-C to disinfect rooms where patients with the target bacteria had been staying.
How Architects Shape the Future of Healthcare Facilities
UNC Health, Duke Health Form Partnership for Stand-alone Children's Hospital
Sarasota Memorial Hospital Plans to Build New Facility in North Port
CMMS, Data and the Path to Compliance
Healthcare is a Major Ransomware Target